Clinical Biomarkers

Purpose and scope

This scheme supports the identification, validation, and implementation of clinical biomarkers that bring us closer to an early and accurate diagnosis, and/or inform the management of brain tumours.

Studies may make use of the samples and infrastructure brought about by funded clinical trials, to go beyond the primary and secondary endpoints and generate new knowledge around clinical biomarkers.

Please read our Grant Conditions, Finance Guidelines, and Data Protection Statement before applying for funding.

Funding

Up to £100,000 per year for up to five years can be requested.

Eligibility criteria

  • Applications must include a Clinical Lead and a Scientific Lead
  • Both the Clinical Lead and Scientific Lead must hold an employment contract beyond the period of the grant
  • All applications must address the issue of earlier and accurate diagnosis, as highlighted in our research strategy 'A Cure Can't Wait'
  • This award is open to international researchers but all proposals must demonstrate how they can benefit patients in the UK health system
  • If the proposed research makes use of the infrastructure and/or samples already in use for a funded trial, the funding obtained may not be used for the purposes of achieving the primary or second endpoints of the trial.
  • All applications must have input from those affected by brain tumours as early as possible, preferably during scoping of the project

Public and patient involvement

To obtain input from those affected by brain tumours, we strongly recommend that applicants access our Research Involvement Network (RIN). In order to receive feedback from the RIN, please allow for a minimum of 3 weeks turnaround time.

Key Dates

Call open: 25 June 2018

Application deadline: 03 September 2018

Funding decision: 11 March 2019


Call open: 07 January 2019

Application deadline: 18 March 2019

Funding decision: September 2019

Application Process

Applications must be submitted online through our Grant Management Portal:

https://grants.thebraintumourcharity.org

Please see our Clinical Biomarkers Guidance Notes, below, for more information.

Please take note of, and allow sufficient time for, the approval steps required to complete the submission process. We cannot guarantee late submissions will be accepted.

Assessment criteria

Methodology

Projects must have a sound approach and methodology in order to address the questions raised

Proposals that make use of the infrastructure and/or samples, already in use for a funded trial, are strongly encouraged

Statistical validity

Projects must be statistically powered so results are significant and meaningful

Expertise of applicants

The applicants must be appropriately trained and well suited to carry out the planned studies

Potential for patient benefit

Projects must articulate a clear pathway leading to patient benefit as well as the anticipated impact and likelihood of achieving an early and accurate diagnosis

Applications with a clear path to clinical or practical application will be strongly favoured

Applicants must demonstrate how their findings will be taken up and funded by the NHS following The Charity's investment

Value for money

Projects must demonstrate that the funds requested are essential for the work and how these represent value for money

Further information

If you would like to discuss project ideas or need any information, please contact the Research Team.
E-mail: research@thebraintumourcharity.org
Phone: +44 (0) 1252 418190

We promise to keep your data safe and you can unsubscribe at any time in the future. More information is in our Privacy Policy.